Earnings
📈 Stocks
Oxford Biomedica Revenue Rises 10% as Manufacturing Demand Strengthens
(just now)
Oxford Biomedica posted improved H1 results with a 10% revenue gain and 22 new client signings, though management acknowledged minor program delays…